Cytoskeletal and Cytoskeleton-Associated Proteins: Key Regulators of Cancer Stem Cell Properties
Cancer stem cells (CSCs) are a subpopulation of cancer cells possessing stemness characteristics that are closely associated with tumor proliferation, recurrence and resistance to therapy. Recent studies have shown that different cytoskeletal components and remodeling processes have a profound impac...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2022-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_86bcc1ab1b0a4eeeba23c8dc7d8d2054 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Yuqiang Li |e author |
| 700 | 1 | 0 | |a Dan Wang |e author |
| 700 | 1 | 0 | |a Heming Ge |e author |
| 700 | 1 | 0 | |a Cenap Güngör |e author |
| 700 | 1 | 0 | |a Xuejun Gong |e author |
| 700 | 1 | 0 | |a Yongheng Chen |e author |
| 245 | 0 | 0 | |a Cytoskeletal and Cytoskeleton-Associated Proteins: Key Regulators of Cancer Stem Cell Properties |
| 260 | |b MDPI AG, |c 2022-11-01T00:00:00Z. | ||
| 500 | |a 10.3390/ph15111369 | ||
| 500 | |a 1424-8247 | ||
| 520 | |a Cancer stem cells (CSCs) are a subpopulation of cancer cells possessing stemness characteristics that are closely associated with tumor proliferation, recurrence and resistance to therapy. Recent studies have shown that different cytoskeletal components and remodeling processes have a profound impact on the behavior of CSCs. In this review, we outline the different cytoskeletal components regulating the properties of CSCs and discuss current and ongoing therapeutic strategies targeting the cytoskeleton. Given the many challenges currently faced in targeted cancer therapy, a deeper comprehension of the molecular events involved in the interaction of the cytoskeleton and CSCs will help us identify more effective therapeutic strategies to eliminate CSCs and ultimately improve patient survival. | ||
| 546 | |a EN | ||
| 690 | |a cytoskeletal | ||
| 690 | |a cytoskeleton-associated proteins | ||
| 690 | |a cancer stem cells | ||
| 690 | |a recurrence | ||
| 690 | |a metastasis | ||
| 690 | |a drug resistance | ||
| 690 | |a Medicine | ||
| 690 | |a R | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Pharmaceuticals, Vol 15, Iss 11, p 1369 (2022) | |
| 787 | 0 | |n https://www.mdpi.com/1424-8247/15/11/1369 | |
| 787 | 0 | |n https://doaj.org/toc/1424-8247 | |
| 856 | 4 | 1 | |u https://doaj.org/article/86bcc1ab1b0a4eeeba23c8dc7d8d2054 |z Connect to this object online. |